Ramiro Ribeiro
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Ramiro Ribeiro is currently Chief Medical Officer at EyePoint, Inc. since 2024.
Formerly, Dr. Ribeiro was Vice President & Head-Clinical Development at Apellis Pharmaceuticals, Inc. from 2018 to 2024.
Education includes doctorates from Universidade Federal De Sao Paulo and Pontificia Universidade Catolica Do Parana.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EYEPOINT, INC. -.--% | 21-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EYEPOINT, INC. | Hoofd Techniek/Wetenschap/O&O | 04-03-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Pontificia Universidade Catolica Do Parana
Pontificia Universidade Catolica Do Parana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidade Federal De Sao Paulo
Universidade Federal De Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau